compound 23
oral CAT K inhibitior reduced uCTX-I levels in dog model from opt of a previously disclosed cmpd Bioorg. Med. Chem. Lett. Merck, West Point, PA
Molecules of the Month - August 2022
3 minute read
Sep. 28, 2022
“Compound 23 ” (Merck) is a Selective Oral Cathepsin K (CatK) Inhibitor